Improved survival and decreased cancer deaths in young adults with cancer after passage of the Affordable Care Act Dependent Coverage Expansion.

Patient Protection and Affordable Care Act Dependent Coverage Expansion (ACA DCE) cancer deaths health insurance state Medicaid survival young adults

Journal

Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236

Informations de publication

Date de publication:
07 Oct 2024
Historique:
revised: 02 08 2024
received: 07 05 2024
accepted: 06 08 2024
medline: 7 10 2024
pubmed: 7 10 2024
entrez: 7 10 2024
Statut: aheadofprint

Résumé

The Patient Protection and Affordable Care Act (ACA) allowed Americans aged 19-25 years to remain on their parents' health insurance plans until age 26 years (the Dependent Care Expansion [DCE]). Have those with cancer diagnoses benefited? The ACE DCE 7-year age range of 19-25 years was compared for changes in cancer survival and mortality before and after enactment of the ACA with groups that were younger and older (in 7-year age spans: ages 12-18 and 26-32 years, respectively). Cancer death data for the entire United States were obtained from the Centers for Disease Control and Prevention, and relative survival data of patients who were diagnosed with cancer were obtained from the National Cancer Institute Surveillance, Epidemiology, and End Results regions representing 42%-44% of the country. Joinpoint analysis identified the DCE-eligible cohort as the only age group of the three groups evaluated that have had improvements in both cancer survival and death rate trends after ACA implementation and that 2010, the year the ACA was passed, was the inflection year for both survival and deaths. By 6 years, the relative survival after cancer diagnosis was 2.6 and 3.9 times greater in the DCE-eligible age group than in the younger and older control groups, respectively (both p < .001), and the cancer death rate in the DCE-eligible age group improved 2.1 and 1.5 times greater than in the younger and older control age groups, respectively (both p < .01). During the first decade of the ACA, eligible young adults with cancer have had significantly improved survival and mortality. Additional policies expanding insurance coverage and enabling earlier cancer diagnosis among young adults are needed. The Patient Protection and Affordable Care Act (ACA) Dependent Care Expansion (DCE) that began in the United States in 2011 allowed young adults aged 19-25 years to remain on their parents' health insurance plans until age 26 years. The survival rate at 6 years in young adult patients diagnosed with cancer was 2.6 to 3.9 times greater in the DCE-eligible age group compared with the younger and older age groups, and the rate of deaths from cancer improved 1.5 to 2.1 times more. During the first decade of the ACA, young adults with cancer who were in the eligible group had significantly longer survival and reduced deaths from cancer. Additional policies that expand insurance coverage and allow the diagnosis of cancer sooner are needed in young adults.

Sections du résumé

BACKGROUND BACKGROUND
The Patient Protection and Affordable Care Act (ACA) allowed Americans aged 19-25 years to remain on their parents' health insurance plans until age 26 years (the Dependent Care Expansion [DCE]). Have those with cancer diagnoses benefited?
METHODS METHODS
The ACE DCE 7-year age range of 19-25 years was compared for changes in cancer survival and mortality before and after enactment of the ACA with groups that were younger and older (in 7-year age spans: ages 12-18 and 26-32 years, respectively). Cancer death data for the entire United States were obtained from the Centers for Disease Control and Prevention, and relative survival data of patients who were diagnosed with cancer were obtained from the National Cancer Institute Surveillance, Epidemiology, and End Results regions representing 42%-44% of the country.
RESULTS RESULTS
Joinpoint analysis identified the DCE-eligible cohort as the only age group of the three groups evaluated that have had improvements in both cancer survival and death rate trends after ACA implementation and that 2010, the year the ACA was passed, was the inflection year for both survival and deaths. By 6 years, the relative survival after cancer diagnosis was 2.6 and 3.9 times greater in the DCE-eligible age group than in the younger and older control groups, respectively (both p < .001), and the cancer death rate in the DCE-eligible age group improved 2.1 and 1.5 times greater than in the younger and older control age groups, respectively (both p < .01).
CONCLUSIONS CONCLUSIONS
During the first decade of the ACA, eligible young adults with cancer have had significantly improved survival and mortality. Additional policies expanding insurance coverage and enabling earlier cancer diagnosis among young adults are needed.
PLAIN LANGUAGE SUMMARY CONCLUSIONS
The Patient Protection and Affordable Care Act (ACA) Dependent Care Expansion (DCE) that began in the United States in 2011 allowed young adults aged 19-25 years to remain on their parents' health insurance plans until age 26 years. The survival rate at 6 years in young adult patients diagnosed with cancer was 2.6 to 3.9 times greater in the DCE-eligible age group compared with the younger and older age groups, and the rate of deaths from cancer improved 1.5 to 2.1 times more. During the first decade of the ACA, young adults with cancer who were in the eligible group had significantly longer survival and reduced deaths from cancer. Additional policies that expand insurance coverage and allow the diagnosis of cancer sooner are needed in young adults.

Identifiants

pubmed: 39370757
doi: 10.1002/cncr.35538
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 American Cancer Society.

Références

United States Census Bureau. Another Look at Health Insurance Coverage Rates for Young Adults. United States Census Bureau; 2021. Accessed February 4, 2024. https://www.census.gov/newsroom/blogs/random‐samplings/2018/09/another_look_at_heal.html
Sommers BD, Buchmueller T, Decker SL, Carey C, Kronick R. The Affordable Care Act has led to significant gains in health insurance and access to care for young adults. Health Aff (Millwood). 2013;32(1):165‐174. doi:10.1377/hlthaff.2012.0552
Rodean J. Health Insurance Coverage of Young Adults Aged 19 to 25: 2008, 2009, and 2011. Report No. ASCR/11‐11. United States Census Bureau; 2012. Accessed February 4, 2024. https://www.census.gov/library/publications/2012/acs/acsbr11‐11.html
Shaw PH, Boyiadzis M, Tawbi H, et al. Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions. Cancer. 2012;118(14):3614‐3627. doi:10.1002/cncr.26634
Buchmueller TC, Levinson ZM, Levy HG, Wolfe BL. Effect of the Affordable Care Act on racial and ethnic disparities in health insurance coverage. Am J Public Health. 2016;106(8):1416‐1421. doi:10.2105/AJPH.2016.303155
Centers for Medicare and Medicaid Services (CMS). Medicaid.gov State Profiles. CMS; 2024. Accessed April 30, 2024. https://www.medicaid.gov/state‐overviews/state‐profiles/index.html
Liu L, Moke DJ, Tsai KY, et al. A reappraisal of sex‐specific cancer survival trends among adolescents and young adults in the United States. J Natl Cancer Inst. 2019;111(5):509‐518. doi:10.1093/jnci/djy140
Moke DJ, Tsai K, Hamilton AS, et al. Emerging cancer survival trends, disparities, and priorities in adolescents and young adults: a California Cancer Registry‐based study. JNCI Cancer Spectr. 2019;3(2):pkz031. doi:10.1093/jncics/pkz031
Bleyer A, Barr R, Hayes‐Lattin B, et al.; Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult Oncology. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8(4):288‐298. doi:10.1038/nrc2349
Barr RD, Ferrari A, Ries L, Whelan J, Bleyer WA. Cancer in adolescents and young adults: a narrative review of the current status and a view of the future. JAMA Pediatr. 2016;170(5):495‐501. doi:10.1001/jamapediatrics.2015.4689
Bleyer A, Tai E, Siegel S. Role of clinical trials in survival progress of American adolescents and young adults with cancer—and lack thereof. Pediatr Blood Cancer. 2018;65(8):e27074. doi:10.1002/pbc.27074
Zebrack B, Bleyer A, Albritton K, Medearis S, Tang J. Assessing the health care needs of adolescent and young adult cancer patients and survivors. Cancer. 2006;107(12):2915‐2923. doi:10.1002/cncr.22338
Albritton KH, Wiggins CH, Nelson HE, Weeks JC. Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol. 2007;25(29):4616‐4621. doi:10.1200/JCO.2006.08.4103
LIVESTRONG Young Adult Alliance. Closing the gap: a strategic plan. Addressing the recommendations of the Adolescent and Young Adult Oncology Progress Review Group. Lance Armstrong Foundation; 2007.
Bleyer A, Ulrich C, Martin S. Young adults, cancer, health insurance, socioeconomic status, and the Patient Protection and Affordable Care Act. Cancer. 2012;118(24):6018‐6021. doi:10.1002/cncr.27685
Adams SH, Newacheck PW, Park MJ, Brindis CD, Irwin CE Jr. Health insurance across vulnerable ages: patterns and disparities from adolescence to the early 30s. Pediatrics. 2007;119(5):e1033‐e1039. doi:10.1542/peds.2006‐1730
Parsons HM, Schmidt S, Harlan LC, et al.; AYA HOPE Collaborative. Young and uninsured: insurance patterns of recently diagnosed adolescent and young adult cancer survivors in the AYA HOPE study. Cancer. 2014;120(15):2352‐2360. doi:10.1002/cncr.28685
Rosenberg AR, Kroon L, Chen L, Li CI, Jones B. Insurance status and risk of cancer mortality among adolescents and young adults. Cancer. 2015;121(8):1279‐1286. doi:10.1002/cncr.29187
Smith EC, Ziogas A, Anton‐Culver H. Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults. Cancer. 2012;118(24):6179‐6187. doi:10.1002/cncr.27684
Martin S, Ulrich C, Munsell M, Taylor S, Lange G, Bleyer A. Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist. 2007;12(7):816‐824. doi:10.1634/theoncologist.12‐7‐816
Roth M, Berkman A, Andersen CR, et al. Improved survival of young adults with cancer following the passage of the Affordable Care Act. Oncologist. 2022;27(2):135‐143. doi:10.1093/oncolo/oyab049
Winestone LE, Hochman LL, Sharpe JE, et al. Impact of Dependent Coverage Provision of the Affordable Care Act on insurance continuity for adolescents and young adults with cancer. JCO Oncol Pract. 2021;17(6):e882‐e890. doi:10.1200/OP.20.00330
Breslau J, Stein BD, Han B, Shelton S, Yu H. Impact of the Affordable Care Act's Dependent Coverage Expansion on the health care and health status of young adults: what do we know so far? Med Care Res Rev. 2018;75(2):131‐152. doi:10.1177/1077558716682171
National Center for Health Statistics, Centers for Disease Control and Prevention (CDC). CDC WONDER. Underlying Cause of Death, 1968–1998, 1999–2020 and 2018–2022 databases. Mortality Statistics Branch, Division of Vital Statistics, National Center for Health Statistics; CDC; 2024. Accessed February 3, 2024. http://wonder.cdc.gov/ucd‐icd10‐expanded.html
Surveillance, Epidemiology, and End Results (SEER) Program; National Cancer Institute. SEER*Stat Beta. Version 9.0.30.0. Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute. Accessed February 19, 2024. https://seer.cancer.gov/seerstat/beta/index.html
Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence‐SEER Research Limited‐Field Data. 22 Registries, November 2022 Submission (2000–2020)‐Linked To County Attributes‐Time Dependent (1990–2021) Income/Rurality, 1969–2021 Counties. Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute; 2023.
Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, eds. SEER Summary Staging Manual—2000: Codes and Coding Instructions. NIH Publication No. 01‐4969. National Cancer Institute; 2001.
National Cancer Institute. Joinpoint Regression Program, Version 5.0.1. Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute; 2023. Accessed April 30, 2024. https://surveillance.cancer.gov/joinpoint/
Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335‐351 [erratum in Stat Med. 2001;20:655]. doi:10.1002/(sici)1097‐0258(20000215)19:3<335::aid‐sim336>3.0.co;2‐z
Surveillance, Epidemiology, and End Results (SEER) Program. SEER Combined Summary Stage 2000 (2004–2017) and Derived Summary Stage 2018 (2018+). SEER Program, National Cancer Institute; 2024. Accessed April 30, 2024. https://seer.cancer.gov/seerstat/variables/seer/lrd‐stage
Nogueira LM, Chawla N, Han X, Jemal A, Yabroff KR. Patterns of coverage gains among young adult cancer patients following the Affordable Care Act. JNCI Cancer Spectr. 2019;3(1):pkz001. doi:10.1093/jncics/pkz001
Ji X, Shi KS, Mertens AC, et al. Survival in young adults with cancer is associated with Medicaid expansion through the Affordable Care Act. J Clin Oncol. 2023;41(10):1909‐1920. doi:10.1200/JCO.22.01742
Ji X, Shi KS, Ruddy KJ, et al. Medicaid expansion is associated with treatment receipt, timeliness, and outcomes among young adults with breast cancer. JNCI Cancer Spectr. 2023;7(5):pkad067. doi:10.1093/jncics/pkad067
Barnes JM, Graboyes EM, Adjei Boakye E, et al. The Affordable Care Act and suicide incidence among adults with cancer. J Cancer Surviv. 2023;17(2):449‐459. doi:10.1007/s11764‐022‐01205‐z
Yang NN, Fan Q, Yabroff KR, Xuesong H, Han X. Health insurance coverage among incident cancer cases from population‐based cancer registries in 49 US states, 2010–2019. Health Aff Sch. 2024;2(1):qxad083. doi:10.1093/haschl/qxad083
Robbins AS, Lerro CC, Barr RD. Insurance status and distant‐stage disease at diagnosis among adolescent and young adult patients with cancer aged 15 to 39 years: National Cancer Data Base, 2004 through 2010. Cancer. 2014;120(8):1212‐1219. doi:10.1002/cncr.28568
Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol. 2015;33(27):3029‐3035. doi:10.1200/jco.2014.59.4895
Han X, Zang Xiong K, Kramer MR, Jemal A. The Affordable Care Act and cancer stage at diagnosis among young adults. J Natl Cancer Inst. 2016;108(9):djw058. doi:10.1093/jnci/djw058
Nogueira L, Chawla N, Han X, Jemal A, Yabroff KR. Colorectal cancer care among young adult patients after the Dependent Coverage Expansion under the Affordable Care Act. J Natl Cancer Inst. 2020;112(10):1063‐1066. doi:10.1093/jnci/djz235
Keegan THM, Parsons HM, Chen Y, et al. Impact of health insurance on stage at cancer diagnosis among adolescents and young adults. J Natl Cancer Inst. 2019;111(11):1152‐1160. doi:10.1093/jnci/djz039
Cuglievan B, Berkman A, Dibaj S, et al. Impact of lagtime, health insurance type and income status at diagnosis on the long‐term survival of adolescent and young adult cancer patients. J Adolesc Young Adult Oncol. 2021;10(2):164‐174. doi:10.1089/jayao.2020.0041
Barr RD, Ries LAG, Lewis DR, et al.; for the US National Cancer Institute Science of Adolescent and Young Adult Oncology Epidemiology Working Group. Incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including “nonmalignant/noninvasive”. Cancer. 2016;122(1000):8. doi:10.1002/cncr.29867
Bleyer A, Ferrari A, Osborn M, Ries L, Barr R. Adolescents and young adults with cancer. In: Devita L, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 12th ed. 2023:1333‐1352.
Johnson RH, Chien FL, Bleyer A. Incidence of breast cancer with distant involvement among women in the United States. JAMA. 2013;309(8):800‐805. doi:10.1001/jama.2013.776
Chen W. Young adults selection and use of dependent coverage under the Affordable Care Act. Front Public Health. 2018;6:3. doi:10.3389/fpubh.2018.00003
Gingrich AA, Sauder CAM, Goldfarb M, Li Q, Wun T, Keegan THM. Disparities in the occurrence of late effects following treatment among adolescent and young adult melanoma survivors. Cancer Epidemiol Biomarkers Prev. 2020;29(11):2195‐2202. doi:10.1158/1055‐9965.epi‐20‐0427
Muffly L, Maguire FB, Li Q, Kennedy V, Keegan TH. Late effects in survivors of adolescent and young adult acute lymphoblastic leukemia. JNCI Cancer Spectr. 2020;4(4):pkaa025. doi:10.1093/jncics/pkaa025
Kirchhoff AC, Waters AR, Chevrier A, Wolfson JA. Access to care for adolescents and young adults with cancer in the United States: state of the literature. J Clin Oncol. 2024;42(6):642‐652. doi:10.1200/JCO.23.01027

Auteurs

Michael Roth (M)

Division of Pediatrics and Patient Care, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Clark R Andersen (CR)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Amy Berkman (A)

Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.

Stuart Siegel (S)

Adolescent and Young Adult Cancer Coalition, Brentwood, Tennessee, USA.

Branko Cuglievan (B)

Division of Pediatrics and Patient Care, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

J Andrew Livingston (JA)

Division of Pediatrics and Patient Care, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Michelle Hildebrandt (M)

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Jaime Estrada (J)

Texas Doctors for Social Responsibility, San Antonio, Texas, USA.

Archie Bleyer (A)

Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon, USA.
Department of Pediatrics, McGovern Medical School, University of Texas, Houston, Texas, USA.

Classifications MeSH